Facebook Twitter YouTube SoundCloud RSS
 

Pfizer to Test 3rd COVID Shot in Kids Under 5 After Two Doses Fall Short

Pfizer and BioNTech will expand their clinical trial to include a third dose of their COVID vaccine on infants and children 6 months to 5 years old after the company said two doses failed to trigger a sufficient immune response in 2- to 5-year-olds.